Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.

ABSTRACT:

SUBMITTER: Ding W 

PROVIDER: S-EPMC3975807 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature